IP Library Granted Patent US 7,897,766
Granted Patent B2
US 7,897,766 · App. 11/517,064 · Granted Mar 1, 2011

Amino-aza-adamantane derivatives and methods of use

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,897,766
App. No.
11/517,064
Granted
Mar 1, 2011
Kind
B2
Abstract

The invention relates to amine-substituted aza-adamantane derivatives, compositions comprising such compounds, and methods of treating conditions and disorders using such compounds and compositions. Radiolabelled compounds useful for evaluating the binding affinity to α7 nicotinic acetylcholine receptors also are described.

Claims (38)

1. A compound of formula (I)

or a pharmaceutically acceptable salt thereof, wherein

X 1 is a bond;

A is benzofuranyl, benzoxadiazolyl, benzoisoxazole, benzoisothiazole, benzooxazole, 1,3-benzothiazolyl, benzodioxolyl, benzothiophenyl, chromenyl, cinnolinyl, furyl, furopyridine, isoquinolinyl, isobenzofuran, isoxazolyl, isothiazolyl, naphthyridinyl, oxadiazolyl, oxazolyl, oxazolopyridine, pyrazolyl, pyrrolyl, pyridazinyl, pyradinyl, pyrazinyl, pyrimidinyl, quinoxalinyl, quinolinyl, thiazolyl, thienyl, thienopyridine, thiadiazolyl, triazolyl, triazinyl and thienopyridinyl; and

R 1 is selected from the group consisting of hydrogen and C 1 -C 6 alkyl.

2. The compound according to claim 1 , wherein

A is selected from the group consisting of 6-(1,3-benzothiazolyl), 5-benzodioxolyl, 2-benzothiophenyl, 3-benzothiophenyl, 5-benzothiophenyl, 3-chromenyl, 5 -thieno [2,3-c] pyridinyl and 6-thieno [3,2-c] pyridinyl.

3. The compound according to claim 1 , wherein

A is

X 2 is selected from the group consisting of —O—, and —S—;

one of X 4 , X 5 , X 6 and X 7 may be nitrogen and the others are CR a ; and

each occurrence of R a is hydrogen.

4. A compound selected from the group consisting of

benzo [b] thiophene-2-carboxylic acid (4r)-(1-azatricyclo[3.3.1.1 3,7 ]dec-4-yl)-amide;

benzo [b] thiophene-2-carboxylic acid (4s)-(1-azatricyclo[3.3.1.1 3,7 ]dec-4-yl)-amide;

benzo [b] thiophene-3-carboxylic acid (4r)-(1-azatricyclo[3.3.1.1 3,7 ]dec-4-yl)-amide;

benzo [b] thiophene-3-carboxylic acid (4s)-(1-azatricyclo[3.3.1.1 3,7 ]dec-4-yl)-amide;

benzo [b] thiophene-5-carboxylic acid (4r)-(1-azatricyclo[3.3.1.1 3,7 ]dec-4-yl)-amide;

benzo [b] thiophene-5-carboxylic acid (4s)-(1-azatricyclo[3.3.1.1 3,7 ]dec-4-yl)-amide;

thieno[2,3-c]pyridine-5-carboxylic acid (4r)-(1-azatricyclo[3.3.1.1 3,7 ]dec-4-yl)-amide;

thieno[2,3-c]pyridine-5-carboxylic acid (4s)-(1-azatricyclo[3.3.1.1 3,7 ]dec-4-yl)-amide;

thieno[3,2-c]pyridine-5-carboxylic acid (4r)-(1-azatricyclo[3.3.1.1 3,7 ]dec-4-yl)-amide;

thieno[3,2-c]pyridine-5-carboxylic acid (4s)-(1-azatricyclo[3.3.1.1 3,7 ]dec-4-yl)-amide;

benzothiazole-6-carboxylic acid (4r)-(1-azatricyclo[3.3.1.1 3,7 ]dec-4-yl)-amide;

benzothiazole-6-carboxylic acid (4s)-(1-azatricyclo[3.3.1.1 3.7 ]dec-4-yl)-amide;

2-aminobenzothiazole-6-carboxylic acid (4r)-(1-azatricyclo[3.3.1.1 3,7 ]dec-4-yl)-amide;

furo[2,3-c]pyridine-5-carboxylic acid (1-aza-tricyclo[3.3.1.1 3,7 ]dec-4-yl)-amide;

3-methyl-benzofuran-2-carboxylic acid (1-aza-tricyclo[3.3.1.1 3,7 ]dec-4-yl)-amide;

furo[2,3-c]pyridine-5-carboxylic acid (1-aza-tricyclo[3.3.1.1 3,7 ]dec-4-yl)-amide;

benzofuran-2-carboxylic acid(4r)-(1-azatricyclo[3.3.1.1 3,7 ]dec-4-yl)-amide;

benzo[d][1,2,3]thiadiazole-5-carboxylic acid (4r)-(1-azatricyclo[3.3.1.1 3,7 ]dec-4-yl)-amide;

isoquinoline-3-carboxylic acid (4r)-(1-azatricyclo[3.3.1.1 3,7 ]dec-4-yl)-amide;

benzo[c][1,2,5]thiadiazole-5-carboxylic acid (4r)-(1-azatricyclo[3.3.1.1 3,7 ]dec-4-yl)-amide;

thieno[3,2-b]thiophene-2-carboxylic acid (4r)-(1-azatricyclo[3.3.1.1 3,7 ]dec-4-yl)-amide;

thieno[2,3-b]thiophene-2-carboxylic acid (4r)-(1-azatricyclo[3.3.1.1 3,7 ]dec-4-yl)-amide;

5-chlorobenzofuran-2-carboxylic acid (4r)-(1-azatricyclo[3.3.1.1 3,7 ]dec-4-yl)-amide;

1H-indazole-3-carboxylic acid (4r)-(1-azatricyclo[3.3.1.1 3,7 ]dec-4-yl)-amide; and

1H-indazole-4-carboxylic acid (4r)-(1-azatricyclo[3.3.1.1 3,7 ]dec-4-yl)-amide.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 10, 2013
From: ABBOTT LABORATORIES
To: ABBVIE INC.
Reel/Frame 030185/0141 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 13, 2006
From: SCHRIMPF, MICHAEL R.; SIPPY, KEVIN B.; ANDERSON, DAVID J.; BUNNELLE, WILLIAM H.; NERSESIAN, DIANA L.
To: ABBOTT LABORATORIES
Reel/Frame 018387/0174 →